KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Goodwill (2021 - 2025)

Fulgent Genetics (FLGT) has disclosed Goodwill for 5 consecutive years, with $25.1 million as the latest value for Q4 2025.

  • Quarterly Goodwill rose 13.72% to $25.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.1 million through Dec 2025, up 13.72% year-over-year, with the annual reading at $25.1 million for FY2025, 13.72% up from the prior year.
  • Goodwill hit $25.1 million in Q4 2025 for Fulgent Genetics, roughly flat from $25.1 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $143.1 million in Q1 2023 to a low of $22.1 million in Q4 2023.
  • Historically, Goodwill has averaged $61.5 million across 5 years, with a median of $25.1 million in 2025.
  • Biggest five-year swings in Goodwill: surged 425.18% in 2022 and later tumbled 84.59% in 2024.
  • Year by year, Goodwill stood at $50.9 million in 2021, then surged by 137.68% to $121.0 million in 2022, then crashed by 81.77% to $22.1 million in 2023, then changed by 0.0% to $22.1 million in 2024, then grew by 13.72% to $25.1 million in 2025.
  • Business Quant data shows Goodwill for FLGT at $25.1 million in Q4 2025, $25.1 million in Q3 2025, and $22.1 million in Q2 2025.